Jane Street’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Jane Street’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-120,800	Closed	-$1.48M	–	10486
2022 Q4	$1.48M	Buy	120,800 +88,700	+276%	+$2.11M	﹤0.01%	4331
2022 Q3	$1.05M	Buy	+32,100	New	+$907K	﹤0.01%	5326

Jane Street's CINC Position: Q1 2023 in Review

Jane Street sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 18,342 shares — an estimated $225K sold.

Jane Street first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $225K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Jane Street reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Jane Street sold 18,342 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $225K.
Jane Street first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Jane Street's CinCor Pharma, Inc. Common Stock position peaked at $225K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.